Biotech

All Articles

Metsera coordinate with Amneal to secure down GLP-1 supply

.With early stage 1 information today out in the wild, metabolic disease clothing Metsera is squande...

Rivus posts records to back up muscle-sparing excessive weight medication insurance claims

.Rivus Pharmaceuticals has unveiled the records behind its own phase 2 excessive weight gain in hear...

BMS pays out $110M to develop T-cell treatment treaty, assisting Best acquire opportunity to develop prioritized pipe

.Bristol Myers Squibb is paying for Prime Medicine $110 million in advance to establish reagents for...

Generate gains one more $1B-plus Major Pharma partnership

.Novartis has printer inked an offer potentially worth greater than $1 billion along with Flagship-f...

Metsera GLP-1 records slice exposes 7.5% fat loss at 36 times

.Just recently debuted Metsera is actually unfolding some stage 1 record for its GLP-1 receptor agon...

Flagship wishes biotechs flock to Mirai to enhance genetic meds

.In the middle of the hereditary medicines branches ethnicity, Front runner Pioneering is unveiling ...

BioAge eyes $180M from IPO, private positioning for weight problems trials

.BioAge Labs is looking at all around $180 million in initial profits from an IPO and a private posi...

Merck's LAG-3 combo falls short colorectal cancer cells phase 3 study

.An effort by Merck &amp Co. to unlock the microsatellite dependable (MSS) metastatic intestines can...

Spanish VC closes $200M life scientific researches fund

.Spain-based Asabys Allies has actually closed a fund of 180 thousand euros ($ 200 million), cash th...

BioAge generates $198M coming from IPO as excessive weight biotech signs up with Nasdaq

.BioAge Labs is generating just about $200 million through its Nasdaq IPO today, with the proceeds s...